29-Jul-2022
Download PDF
Cipla
We refer the investor presentation submitted through letter dated 29th July 2022. Please note that there was a minor error in the graphical presentation of the information in slide 11 (titled North America: Respiratory Complex generics & Peptide pipeline). In the slide the status of progress of Complex inhalation asset was erroneously shown as Approved instead of the actual status as Filed. We are enclosing the updated presentation.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
